| Primary information |
|---|
| Hemolytik ID | 4196 |
| PMID | 16235231 |
| YEAR | 2006 |
| SEQUENCE | ZSRRLCYKQRCVTYSRGR |
| LENGTH | 18 |
| NAME | [Ser2,15]-Gm |
| C-ter Modification | Amidation |
| N-ter Modification | Free |
| Linear/Cyclic | Cyclic |
| Stereochemistry | L |
| Modified Residues | Z= pyroglutamic acid |
| FUNCTION | Antimicrobial |
| ACTIVITY | <10% hemolysis at 100µM |
| RBCs SOURCE | Human |
| Secondary information |
|---|
| Properties | Physico-Chemical details |
| STRUCTURE | |
| DSSP states | NA |
| SMILES | NA |
| External Links |
|---|
| PDB exact | PDB partial | SP exact | SP partial | TrEMBL exact | TrEMBL partial | IEDB exact | IEDB partial |
| NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
|
| Reference Informaiton |
|---|
| ARTICLE | Structure-activity relationship studies of gomesin: importance of the disulfide bridges for conformation, bioactivities, and serum stability. |
| AUTHORS | Fazio MA,Oliveira VX Jr,Bulet P,Miranda MT,Daffre S |
| JOURNAL | Biopolymers. 2006;84(2):205-18. |
